Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 124.93 USD 4.41% Market Closed
Market Cap: 7B USD

Wall Street
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 183.61 USD with a low forecast of 131.3 USD and a high forecast of 231 USD.

Lowest
Price Target
131.3 USD
5% Upside
Average
Price Target
183.61 USD
47% Upside
Highest
Price Target
231 USD
85% Upside
Repligen Corp Competitors:
Price Targets
BIO
Bio Rad Laboratories Inc
8% Upside
NANOFH
Nanoform Finland Oyj
255% Upside
PIQ
Proteomics International Laboratories Ltd
41% Upside
EVT
Evotec SE
56% Upside
603108
Shanghai Runda Medical Technology Co Ltd
32% Upside
MTD
Mettler-Toledo International Inc
1% Downside
603127
Joinn Laboratories China Co Ltd
20% Downside
INNOVACAP
Innova Captab Ltd
20% Upside

Revenue
Forecast

Revenue Estimate
Repligen Corp

For the last 12 years the compound annual growth rate for Repligen Corp's revenue is 21%. The projected CAGR for the next 3 years is 15%.

21%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Repligen Corp

For the last 12 years the compound annual growth rate for Repligen Corp's operating income is 0%. The projected CAGR for the next 3 years is 150%.

0%
Past Growth
150%
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Net Income
Forecast

Net Income Estimate
Repligen Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGEN's stock price target?
Price Target
183.61 USD

According to Wall Street analysts, the average 1-year price target for RGEN is 183.61 USD with a low forecast of 131.3 USD and a high forecast of 231 USD.

What is Repligen Corp's Revenue forecast?
Projected CAGR
15%

For the last 12 years the compound annual growth rate for Repligen Corp's revenue is 21%. The projected CAGR for the next 3 years is 15%.

What is Repligen Corp's Operating Income forecast?
Projected CAGR
150%

For the last 12 years the compound annual growth rate for Repligen Corp's operating income is 0%. The projected CAGR for the next 3 years is 150%.

Back to Top